Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type with significant T-cell immune response.

Graham PM, Richardson AS, Schapiro BL, Saunders MD, Stewart DM.

JAAD Case Rep. 2018 Mar 31;4(4):305-309. doi: 10.1016/j.jdcr.2017.10.012. eCollection 2018 May.

2.

Three-Dimensional Solid-State Lithium-Ion Batteries Fabricated by Conformal Vapor-Phase Chemistry.

Pearse A, Schmitt T, Sahadeo E, Stewart DM, Kozen A, Gerasopoulos K, Talin AA, Lee SB, Rubloff GW, Gregorczyk KE.

ACS Nano. 2018 May 22;12(5):4286-4294. doi: 10.1021/acsnano.7b08751. Epub 2018 Apr 26.

PMID:
29688704
3.

Substance Use Disorder Among Nurses: A Curriculum Improvement Initiative.

Stewart DM, Mueller CA.

Nurse Educ. 2018 May/Jun;43(3):132-135. doi: 10.1097/NNE.0000000000000466.

PMID:
28991035
4.

Inhibition of Receptor-Interacting Protein Kinase 1 with Necrostatin-1s ameliorates disease progression in elastase-induced mouse abdominal aortic aneurysm model.

Wang Q, Zhou T, Liu Z, Ren J, Phan N, Gupta K, Stewart DM, Morgan S, Assa C, Kent KC, Liu B.

Sci Rep. 2017 Feb 10;7:42159. doi: 10.1038/srep42159.

5.

The aging disc: using an ovine model to examine age-related differences in the biomechanical properties of the intralamellar matrix of single lamellae.

Stewart DM, Monaco LA, Gregory DE.

Eur Spine J. 2017 Jan;26(1):259-266. doi: 10.1007/s00586-016-4603-4. Epub 2016 May 10.

PMID:
27165182
6.

The use of intermittent trunk flexion to alleviate low back pain during prolonged standing.

Stewart DM, Gregory DE.

J Electromyogr Kinesiol. 2016 Apr;27:46-51. doi: 10.1016/j.jelekin.2016.01.007. Epub 2016 Feb 9.

PMID:
26897327
7.

90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma.

Janik JE, Morris JC, O'Mahony D, Pittaluga S, Jaffe ES, Redon CE, Bonner WM, Brechbiel MW, Paik CH, Whatley M, Chen C, Lee JH, Fleisher TA, Brown M, White JD, Stewart DM, Fioravanti S, Lee CC, Goldman CK, Bryant BR, Junghans RP, Carrasquillo JA, Worthy T, Corcoran E, Conlon KC, Waldmann TA.

Proc Natl Acad Sci U S A. 2015 Oct 20;112(42):13045-50. doi: 10.1073/pnas.1516107112. Epub 2015 Oct 5.

8.

Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.

Conlon KC, Lugli E, Welles HC, Rosenberg SA, Fojo AT, Morris JC, Fleisher TA, Dubois SP, Perera LP, Stewart DM, Goldman CK, Bryant BR, Decker JM, Chen J, Worthy TA, Figg WD Sr, Peer CJ, Sneller MC, Lane HC, Yovandich JL, Creekmore SP, Roederer M, Waldmann TA.

J Clin Oncol. 2015 Jan 1;33(1):74-82. doi: 10.1200/JCO.2014.57.3329. Epub 2014 Nov 17.

9.

Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.

Berkowitz JL, Janik JE, Stewart DM, Jaffe ES, Stetler-Stevenson M, Shih JH, Fleisher TA, Turner M, Urquhart NE, Wharfe GH, Figg WD, Peer CJ, Goldman CK, Waldmann TA, Morris JC.

Clin Immunol. 2014 Dec;155(2):176-87. doi: 10.1016/j.clim.2014.09.012. Epub 2014 Sep 28.

10.

A randomized, phase 2, dose-ranging study in the treatment of moderate to severe inflammatory facial acne vulgaris with doxycycline calcium.

Leyden JJ, Bruce S, Lee CS, Ling M, Sheth PB, Stewart DM, Werschler WP, Gilbert RD, Kircik L.

J Drugs Dermatol. 2013 Jun 1;12(6):658-63.

PMID:
23839182
11.

Phase 1 trial of IL-15 trans presentation blockade using humanized Mik╬▓1 mAb in patients with T-cell large granular lymphocytic leukemia.

Waldmann TA, Conlon KC, Stewart DM, Worthy TA, Janik JE, Fleisher TA, Albert PS, Figg WD, Spencer SD, Raffeld M, Decker JR, Goldman CK, Bryant BR, Petrus MN, Creekmore SP, Morris JC.

Blood. 2013 Jan 17;121(3):476-84. doi: 10.1182/blood-2012-08-450585. Epub 2012 Dec 3.

12.

Radiation therapy for the management of patients with HTLV-1-associated adult T-cell leukemia/lymphoma.

Simone CB 2nd, Morris JC, Stewart DM, Urquhart NE, Janik JE, Kreitman RJ, Lita E, Conlon K, Wharfe G, Waldmann TA, Kaushal A.

Blood. 2012 Aug 30;120(9):1816-9. doi: 10.1182/blood-2012-01-401349. Epub 2012 Jun 22.

13.

Disseminated Strongyloides stercoralis infection in HTLV-1-associated adult T-cell leukemia/lymphoma.

Stewart DM, Ramanathan R, Mahanty S, Fedorko DP, Janik JE, Morris JC.

Acta Haematol. 2011;126(2):63-7. doi: 10.1159/000324799. Epub 2011 Apr 7.

14.

AOF1 is a histone H3K4 demethylase possessing demethylase activity-independent repression function.

Yang Z, Jiang J, Stewart MD, Qi S, Yamane K, Li J, Zhang Y, Wong J.

Cell Res. 2010 Mar;20(3):276-87. doi: 10.1038/cr.2010.12. Epub 2010 Jan 26. Erratum in: Cell Res. 2010 Jul;20(7):858. Stewart, David M [corrected to Stewart, M David].

15.

Dog bite-related fatalities: a 15-year review of Kentucky medical examiner cases.

Shields LB, Bernstein ML, Hunsaker JC 3rd, Stewart DM.

Am J Forensic Med Pathol. 2009 Sep;30(3):223-30. doi: 10.1097/PAF.0b013e3181a5e558.

PMID:
19696575
16.

Speaking the right language: the scientific method as a framework for a continuous quality improvement program within academic medical research compliance units.

Nolte KB, Stewart DM, O'Hair KC, Gannon WL, Briggs MS, Barron AM, Pointer J, Larson RS.

Acad Med. 2008 Oct;83(10):941-8. doi: 10.1097/ACM.0b013e3181850b2a. Review.

PMID:
18820524
17.

Placebo use in clinical practice: report of the American Medical Association Council on Ethical and Judicial Affairs.

Bostick NA, Sade R, Levine MA, Stewart DM Jr; American Medical Association Council on Ethical and Judicial Affairs.

J Clin Ethics. 2008 Spring;19(1):58-61. No abstract available.

PMID:
18552054
18.

Russian roulette and risk-taking behavior: a medical examiner study.

Shields LB, Hunsaker JC 3rd, Stewart DM.

Am J Forensic Med Pathol. 2008 Mar;29(1):32-9. doi: 10.1097/PAF.0b013e318160675e.

PMID:
19749614
19.

X-linked hypogammaglobulinemia and isolated growth hormone deficiency: an update.

Stewart DM, Tian L, Notarangelo LD, Nelson DL.

Immunol Res. 2008;40(3):262-70. doi: 10.1007/s12026-007-0028-9. Review.

PMID:
18180883
20.

X-linked hypogammaglobulinemia and isolated growth hormone deficiency: an update.

Stewart DM, Tian L, Notarangelo LD, Nelson DL.

Immunol Res. 2007;38(1-3):391-9. Review.

PMID:
17917049
22.

Myofibroblastic tumor of the lower lip in a patient with X-linked hypogammaglobulinemia and isolated growth hormone deficiency: a case report.

Imanguli MM, Karai LJ, Shanti RM, Stewart DM, Brahim JS.

J Oral Maxillofac Surg. 2007 Jun;65(6):1219-22. No abstract available.

PMID:
17517309
23.

Dose-ranging efficacy of new once-daily extended-release minocycline for acne vulgaris.

Stewart DM, Torok HM, Weiss JS, Plott RT; Solodyn Phase 2 Study Group.

Cutis. 2006 Oct;78(4 Suppl):11-20.

PMID:
17436825
24.

Update on X-linked hypogammaglobulinemia with isolated growth hormone deficiency.

Stewart DM, Tian L, Notarangelo LD, Nelson DL.

Curr Opin Allergy Clin Immunol. 2005 Dec;5(6):510-2. Review.

PMID:
16264330
25.

High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID).

Zeeberg BR, Qin H, Narasimhan S, Sunshine M, Cao H, Kane DW, Reimers M, Stephens RM, Bryant D, Burt SK, Elnekave E, Hari DM, Wynn TA, Cunningham-Rundles C, Stewart DM, Nelson D, Weinstein JN.

BMC Bioinformatics. 2005 Jul 5;6:168.

26.

Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation.

Jin Y, Mazza C, Christie JR, Giliani S, Fiorini M, Mella P, Gandellini F, Stewart DM, Zhu Q, Nelson DL, Notarangelo LD, Ochs HD.

Blood. 2004 Dec 15;104(13):4010-9. Epub 2004 Jul 29.

PMID:
15284122
27.

AKAP350 interaction with cdc42 interacting protein 4 at the Golgi apparatus.

Larocca MC, Shanks RA, Tian L, Nelson DL, Stewart DM, Goldenring JR.

Mol Biol Cell. 2004 Jun;15(6):2771-81. Epub 2004 Mar 26.

28.

Tracking gene expression in primary immunodeficiencies.

Qin H, Yamada M, Tian L, Stewart DM, Gulino AV, Nelson DL.

Curr Opin Allergy Clin Immunol. 2003 Dec;3(6):437-42. Review.

PMID:
14612667
29.

B lymphocytes from individuals with common variable immunodeficiency respond to B lymphocyte stimulator (BLyS protein) in vitro.

Stewart DM, McAvoy MJ, Hilbert DM, Nelson DL.

Clin Immunol. 2003 Nov;109(2):137-43.

PMID:
14597212
30.

Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial.

Pariser DM, Lowe NJ, Stewart DM, Jarratt MT, Lucky AW, Pariser RJ, Yamauchi PS.

J Am Acad Dermatol. 2003 Feb;48(2):227-32.

PMID:
12582393
31.

Linking cellular activation to cytoskeletal reorganization: Wiskott-Aldrich syndrome as a model.

Stewart DM, Tian L, Nelson DL.

Curr Opin Allergy Clin Immunol. 2001 Dec;1(6):525-33. Review.

PMID:
11964736
32.

The clinical spectrum of Bruton's agammaglobulinemia.

Stewart DM, Lian L, Nelson DL.

Curr Allergy Asthma Rep. 2001 Nov;1(6):558-65. Review.

PMID:
11892085
33.

Efficacy and tolerance of adapalene cream 0.1% compared with its cream vehicle for the treatment of acne vulgaris.

Lucky A, Jorizzo JL, Rodriguez D, Jones TM, Stewart DM, Tschen EH, Kanof NB, Miller BH, Wilson DC, Loven KH.

Cutis. 2001 Oct;68(4 Suppl):34-40.

PMID:
11845946
34.
35.

A case of win, lose, draw.

Stewart DM Jr.

J La State Med Soc. 2001 Sep;153(9):436-8. No abstract available.

PMID:
11686254
36.

Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin.

Strauss JS, Leyden JJ, Lucky AW, Lookingbill DP, Drake LA, Hanifin JM, Lowe NJ, Jones TM, Stewart DM, Jarratt MT, Katz I, Pariser DM, Pariser RJ, Tschen E, Chalker DK, Rafal ES, Savin RP, Roth HL, Chang LK, Baginski DJ, Kempers S, McLane J, Eberhardt D, Leach EE, Bryce G, Hong J.

J Am Acad Dermatol. 2001 Aug;45(2):196-207.

PMID:
11464180
37.

A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne.

Strauss JS, Leyden JJ, Lucky AW, Lookingbill DP, Drake LA, Hanifin JM, Lowe NJ, Jones TM, Stewart DM, Jarratt MT, Katz I, Pariser DM, Pariser RJ, Tschen E, Chalker DK, Rafal ES, Savin RP, Roth HL, Chang LK, Baginski DJ, Kempers S, McLane J, Eberhardt D, Leach EE, Bryce G, Hong J.

J Am Acad Dermatol. 2001 Aug;45(2):187-95.

PMID:
11464179
38.

The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia/lymphoma.

White JD, Wharfe G, Stewart DM, Maher VE, Eicher D, Herring B, Derby M, Jackson-Booth PG, Marshall M, Lucy D, Jain A, Cranston B, Hanchard B, Lee CC, Top LE, Fleisher TA, Nelson DL, Waldmann TA.

Leuk Lymphoma. 2001 Jan;40(3-4):287-94.

PMID:
11426550
39.

A case of X-linked agammaglobulinemia diagnosed in adulthood.

Stewart DM, Tian L, Nelson DL.

Clin Immunol. 2001 Apr;99(1):94-9.

PMID:
11286545
40.
41.

Interferon-tau activates multiple signal transducer and activator of transcription proteins and has complex effects on interferon-responsive gene transcription in ovine endometrial epithelial cells.

Stewart MD, Johnson GA, Vyhlidal CA, Burghardt RC, Safe SH, Yu-Lee LY, Bazer FW, Spencer TE.

Endocrinology. 2001 Jan;142(1):98-107. Erratum in: Endocrinology. 2010 May;151(5):2400. Stewart, D M [corrected to Stewart, M D].

PMID:
11145571
42.

Cdc42-interacting protein 4 mediates binding of the Wiskott-Aldrich syndrome protein to microtubules.

Tian L, Nelson DL, Stewart DM.

J Biol Chem. 2000 Mar 17;275(11):7854-61.

43.
45.

Defective actin polymerization in EBV-transformed B-cell lines from patients with the Wiskott-Aldrich syndrome.

Facchetti F, Blanzuoli L, Vermi W, Notarangelo LD, Giliani S, Fiorini M, Fasth A, Stewart DM, Nelson DL.

J Pathol. 1998 May;185(1):99-107.

PMID:
9713366
46.

Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingernail.

Savin RC, Drake L, Babel D, Stewart DM, Rich P, Ling MR, Breneman D, Scher RK, Martin AG, Pariser DM, Pariser RJ, Ellis CN, Kang S, Friedman D, Katz HI, McDonald CJ, Muglia J, Webster G, Elewski BE, Leyden JJ, Bucko AD, Tschen EH, Hanifin JM, Morman MR, Hilbert J, et al.

J Am Acad Dermatol. 1998 Jun;38(6 Pt 2):S110-6.

PMID:
9631993
47.

Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail.

Ling MR, Swinyer LJ, Jarratt MT, Falo L, Monroe EW, Tharp M, Kalivas J, Weinstein GD, Asarch RG, Drake L, Martin AG, Leyden JJ, Cook J, Pariser DM, Pariser R, Thiers BH, Lebwohl MG, Babel D, Stewart DM, Eaglstein WH, Falanga V, Katz HI, Bergfeld WF, Hanifin JM, Young MR, et al.

J Am Acad Dermatol. 1998 Jun;38(6 Pt 2):S95-102.

PMID:
9631991
48.

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail.

Drake L, Babel D, Stewart DM, Rich P, Ling MR, Breneman D, Scher RK, Martin AG, Pariser DM, Pariser RJ, Ellis CN, Kang S, Katz HI, McDonald CJ, Muglia J, Savin RC, Webster G, Elewski BE, Leyden JJ, Bucko AD, Tschen EH, Hanifin JM, Morman MR, Shupack JL, Greer DL, et al.

J Am Acad Dermatol. 1998 Jun;38(6 Pt 2):S87-94.

PMID:
9631990
49.

Clobetasol propionate emollient 0.05% in the treatment of atopic dermatitis.

Maloney JM, Morman MR, Stewart DM, Tharp MD, Brown JJ, Rajagopalan R.

Int J Dermatol. 1998 Feb;37(2):142-4.

PMID:
9542676
50.

Supplemental Content

Loading ...
Support Center